Stereochemical engineering yields a multifunctional peptide macrocycle inhibitor of Akt2 by fine-tuning macrocycle-cell membrane interactions

[1]  Keisuke Tsuchiya,et al.  Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity. , 2022, Bioconjugate chemistry.

[2]  Z. Bánóczi,et al.  Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System , 2022, Pharmaceutics.

[3]  A. Caporale,et al.  Recent Applications of Retro-Inverso Peptides , 2021, International journal of molecular sciences.

[4]  P. Ziprin,et al.  Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide , 2020, Scientific Reports.

[5]  D. E. Nichols,et al.  Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor , 2020, Cell.

[6]  J. Heath,et al.  Inhibition of heme sequestration of histidine‐rich protein 2 using multiple epitope‐targeted peptides , 2019, Journal of peptide science : an official publication of the European Peptide Society.

[7]  D. Pei,et al.  Understanding Cell Penetration of Cyclic Peptides. , 2019, Chemical reviews.

[8]  Thomas L. Williams,et al.  Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines , 2019, Scientific Reports.

[9]  Matthew B. Coppock,et al.  Protein-Catalyzed Capture Agents. , 2019, Chemical reviews.

[10]  Susan S. Taylor,et al.  Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores. , 2019, Trends in biochemical sciences.

[11]  Michael D Shultz,et al.  Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. , 2018, Journal of medicinal chemistry.

[12]  J. Heath,et al.  Modulating the Folding Landscape of Superoxide Dismutase 1 with Targeted Molecular Binders. , 2018, Angewandte Chemie.

[13]  A. Verma,et al.  Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia , 2018, Science Translational Medicine.

[14]  James R Heath,et al.  Epitope-Targeted Macrocyclic Peptide Ligand with Picomolar Cooperative Binding to Interleukin-17F. , 2018, Chemistry.

[15]  S. Futaki,et al.  Importance of Net Hydrophobicity in the Cellular Uptake of All-Hydrocarbon Stapled Peptides. , 2018, Molecular pharmaceutics.

[16]  Philip M. Kim,et al.  Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire PDB , 2018, Proceedings of the National Academy of Sciences.

[17]  M. Spehr,et al.  Membrane permeation of arginine‐rich cell‐penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[18]  B. L. de Groot,et al.  CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.

[19]  Chengjie Sun,et al.  An In-tether Chiral Center Modulates the Helicity, Cell Permeability, and Target Binding Affinity of a Peptide. , 2016, Angewandte Chemie.

[20]  Katy Blumer,et al.  Precise quantification of cellular uptake of cell-penetrating peptides using fluorescence-activated cell sorting and fluorescence correlation spectroscopy. , 2016, Biochimica et biophysica acta.

[21]  A. Sutherland,et al.  Degradation of Akt using protein‐catalyzed capture agents , 2016, Journal of peptide science : an official publication of the European Peptide Society.

[22]  Amethist S. Finch,et al.  A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands. , 2015, Angewandte Chemie.

[23]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[24]  K. Pärn,et al.  PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[25]  J. Heath,et al.  Epitope targeting of tertiary protein structure enables target-guided synthesis of a potent in-cell inhibitor of botulinum neurotoxin. , 2015, Angewandte Chemie.

[26]  J. Heath,et al.  Protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH Domain of Akt1 , 2015, Nature chemistry.

[27]  Shadma Parveen,et al.  Computational Insights into the Inhibitory Mechanism of Human AKT1 by an Orally Active Inhibitor, MK-2206 , 2014, PloS one.

[28]  Sunhwan Jo,et al.  CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..

[29]  D. Son,et al.  Preferential Effect of Akt2-Dependent Signaling on the Cellular Viability of Ovarian Cancer Cells in Response to EGF , 2014, Journal of Cancer.

[30]  M. Oba,et al.  Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability. , 2014, Bioorganic & medicinal chemistry.

[31]  J. Heath,et al.  A chemical epitope-targeting strategy for protein capture agents: the serine 474 epitope of the kinase Akt2. , 2013, Angewandte Chemie.

[32]  Massimiliano Bonomi,et al.  PLUMED 2: New feathers for an old bird , 2013, Comput. Phys. Commun..

[33]  W. DeGrado,et al.  Nature-inspired design of motif-specific antibody scaffolds , 2013, Nature Biotechnology.

[34]  D. Craik,et al.  The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.

[35]  W. Lubell,et al.  Peptide Scanning for Studying Structure‐Activity Relationships in Drug Discovery , 2013, Chemical biology & drug design.

[36]  Alexander D. MacKerell,et al.  Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing , 2012, J. Chem. Inf. Model..

[37]  F. Milletti,et al.  Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.

[38]  Horst Kessler,et al.  Intestinal permeability of cyclic peptides: common key backbone motifs identified. , 2012, Journal of the American Chemical Society.

[39]  Yizhong Zhang,et al.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds , 2011, Nature chemical biology.

[40]  E. Simanek,et al.  Conjugation to the Cell-Penetrating Peptide TAT Potentiates the Photodynamic Effect of Carboxytetramethylrhodamine , 2011, PloS one.

[41]  Wadih Arap,et al.  From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway , 2010, Proceedings of the National Academy of Sciences.

[42]  Jason E Hein,et al.  Iterative in situ click chemistry creates antibody-like protein-capture agents. , 2009, Angewandte Chemie.

[43]  W. Göhring,et al.  Cyclic hexapeptides related to somatostatin. Synthesis and biological testing. , 2009, International journal of peptide and protein research.

[44]  K Dane Wittrup,et al.  Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. , 2008, Advanced drug delivery reviews.

[45]  J. Beckmann,et al.  Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. , 2007, Biochimica et biophysica acta.

[46]  M. Parrinello,et al.  Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.

[47]  Matthew P Jacobson,et al.  Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.

[48]  D. Kemp,et al.  Temperature- and length-dependent energetics of formation for polyalanine helices in water: assignment of w(Ala)(n,T) and temperature-dependent CD ellipticity standards. , 2006, Journal of the American Chemical Society.

[49]  A. Laio,et al.  Efficient reconstruction of complex free energy landscapes by multiple walkers metadynamics. , 2006, The journal of physical chemistry. B.

[50]  G. Damonte,et al.  Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  E. Vivés,et al.  Tat peptide-mediated cellular delivery: back to basics. , 2005, Advanced drug delivery reviews.

[52]  Zoran Radić,et al.  In situ click chemistry: enzyme inhibitors made to their own specifications. , 2004, Journal of the American Chemical Society.

[53]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[54]  Andrew K Godwin,et al.  AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth , 2004, Oncogene.

[55]  B. Penke,et al.  Membrane translocation of penetratin and its derivatives in different cell lines , 2003, Journal of Molecular Recognition.

[56]  Brian A. Hemmings,et al.  Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP , 2002, Nature Structural Biology.

[57]  D R Alessi,et al.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.

[58]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[59]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[60]  M. D. Fletcher,et al.  Partially Modified Retro-Inverso Peptides: Development, Synthesis, and Conformational Behavior. , 1998, Chemical reviews.

[61]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[62]  J. Méry,et al.  The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. , 1995, Biochemical and biophysical research communications.

[63]  J. Cheng,et al.  Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas , 1995, International journal of cancer.

[64]  T. Hunter,et al.  Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.

[65]  M. Chorev,et al.  A dozen years of retro-inverso peptidomimetics , 1993 .

[66]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[67]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[68]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[69]  S. Corti,et al.  Therapeutic applications of the cell-penetrating HIV-1 Tat peptide. , 2015, Drug Discovery Today.

[70]  Berk Hess,et al.  P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.

[71]  M. Chorev.  The partial retro–inverso modification: A road traveled together , 2005, Biopolymers.